Mitochondria as potential targets in Alzheimer disease therapy: an update

G Cenini, W Voos - Frontiers in pharmacology, 2019 - frontiersin.org
Alzheimer disease (AD) is a progressive and deleterious neurodegenerative disorder that
affects mostly the elderly population. At the moment, no effective treatments are available in …

Genetics of Alzheimer's disease

V Chouraki, S Seshadri - Advances in genetics, 2014 - Elsevier
Alzheimer's disease (AD) represents the main form of dementia, and is a major public health
problem. Despite intensive research efforts, current treatments have only marginal …

TOMM40 Genetic Variants Cause Neuroinflammation in Alzheimer's Disease

YC Chen, SC Chang, YS Lee, WM Ho… - International Journal of …, 2023 - mdpi.com
Translocase of outer mitochondrial membrane 40 (TOMM40) is located in the outer
membrane of mitochondria. TOMM40 is essential for protein import into mitochondria …

Statistical testing in transcriptomic‐neuroimaging studies: A how‐to and evaluation of methods assessing spatial and gene specificity

Y Wei, SC de Lange, R Pijnenburg, LH Scholtens… - 2022 - Wiley Online Library
Multiscale integration of gene transcriptomic and neuroimaging data is becoming a widely
used approach for exploring the molecular underpinnings of large‐scale brain organization …

Sirtuins in Alzheimer's disease: SIRT2-related genophenotypes and implications for pharmacoepigenetics

R Cacabelos, JC Carril, N Cacabelos… - International journal of …, 2019 - mdpi.com
Sirtuins (SIRT1-7) are NAD+-dependent protein deacetylases/ADP ribosyltransferases with
important roles in chromatin silencing, cell cycle regulation, cellular differentiation, cellular …

Genome‐wide association and multi‐omics studies identify MGMT as a novel risk gene for Alzheimer's disease among women

J Chung, A Das, X Sun, DR Sobreira… - Alzheimer's & …, 2023 - Wiley Online Library
Introduction Variants in the tau gene (MAPT) region are associated with breast cancer in
women and Alzheimer's disease (AD) among persons lacking apolipoprotein E ε4 (ε4–) …

Signaling Mechanisms of Selective PPARγ Modulators in Alzheimer's Disease

M Govindarajulu, PD Pinky, J Bloemer… - PPAR …, 2018 - Wiley Online Library
Alzheimer's disease (AD) is a chronic neurodegenerative disease characterized by
abnormal protein accumulation, synaptic dysfunction, and cognitive impairment. The …

Definitive roles of TOMM40-APOE-APOC1 variants in the Alzheimer's risk

AM Kulminski, I Philipp, L Shu, I Culminskaya - Neurobiology of aging, 2022 - Elsevier
Despite advances, the roles of genetic variants from the APOE-harboring 19q13. 32 region
in Alzheimer's disease (AD) remain controversial. We leverage a comprehensive approach …

APOE Locus-Associated Mitochondrial Function and Its Implication in Alzheimer's Disease and Aging

EG Lee, L Leong, S Chen, J Tulloch, CE Yu - International Journal of …, 2023 - mdpi.com
The Apolipoprotein E (APOE) locus has garnered significant clinical interest because of its
association with Alzheimer's disease (AD) and longevity. This genetic association appears …

[HTML][HTML] The broad impact of TOM40 on neurodegenerative diseases in aging

WK Gottschalk, MW Lutz, YT He… - Journal of Parkinson's …, 2014 - ncbi.nlm.nih.gov
Mitochondrial dysfunction is an important factor in the pathogenesis of age-related diseases,
including neurodegenerative diseases like Alzheimer's and Parkinson's spectrum disorders …